Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis
NCT00936143
Ankylosis, Arthritis
Guangzhou, Guangdong, China
View Trial DetailsNCT Number: NCT00081562
Ankylosing spondylitis (AS) is a chronic inflammatory disease that affects the joints between the vertebrae of the spine and the joints between the spine and the pelvis. The purpose of this study is to collect information and blood samples from patients with AS and their relatives for use in genetic studies.
Looking for future studies?
Notify MeAll sexes
Observational
Cedars-Sinai Medical Center, Los Angeles, California, United States
AS is a chronic inflammatory disease that eventually causes the affected vertebrae to fuse or grow together. The cause of AS is unknown, but genetic factors seem to play a role. Risk factors include a family history of ankylosing spondylitis and male gender.
This study will collect patient information and blood samples from affected patients (and when available, both parents of the affected patients) of 400 families with children fulfillling the modified New York criteria for AS. Diagnosis of AS will be verified by patient questionnaire, medical record review, and pelvic radiographs. Information from these patients will be used to search the human genome for disease-associated loci and/or genes. This study will also utilize contributions of investigators who have conducted recent clinical or genetic research in AS at 10 academic medical centers throughout North America (the North American Spondylitis Consortium, or NASC).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Nih
Family Studies of the Genetics of Ankylosing Spondylitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00936143
Ankylosis, Arthritis
Guangzhou, Guangdong, China
View Trial DetailsNCT07349602
Bone Diseases, Bone Diseases, Infectious
Cheboksary, Chuvashskaya Respublika, Russia
View Trial DetailsNCT03793660
Arthritis, Arthritis, Rheumatoid
Ben Arous, Tunisia
View Trial DetailsNCT00320619
Bone Diseases, Bone Diseases, Infectious
Baltimore, Maryland, United States
View Trial Details